Adocia SA (EPA:ADOC)
4.672
-0.048 (-1.02%)
Apr 24, 2026, 12:33 PM CET
Adocia Market Cap
Adocia has a market cap or net worth of €92.48 million as of April 24, 2026. Its market cap has increased by 47.88% in one year.
Market Cap
92.48M
Enterprise Value
95.85M
Revenue
3.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.67
Market Cap Chart
Since February 20, 2012, Adocia's market cap has decreased from 93.74M to 92.48M, a decrease of -1.34%. That is a compound annual growth rate of -0.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 92.79M | -29.17% |
| Dec 31, 2025 | 131.01M | 40.99% |
| Dec 31, 2024 | 92.92M | -42.69% |
| Dec 29, 2023 | 162.13M | 379.37% |
| Dec 30, 2022 | 33.82M | -41.93% |
| Dec 31, 2021 | 58.24M | 1.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 254.21M |
| Transgene | 208.15M |
| Sensorion | 194.82M |
| ABIONYX Pharma | 130.18M |
| Innate Pharma | 118.04M |
| MaaT Pharma | 100.81M |
| Valerio Therapeutics Société anonyme | 74.30M |
| OSE Immunotherapeutics | 72.42M |